Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese thai subjects

Oseltamivir is the most widely used anti-influenza drug. In the 2009 H1N1 pandemic, in which the influenza viruses were oseltamivir sensitive, obesity was identified as a risk factor for severe disease and unfavorable outcomes. The aim of this study was to investigate the pharmacokinetic properties...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Jittamala, P, Pukrittayakamee, S, Tarning, J, Lindegardh, N, Hanpithakpong, W, Taylor, W, Lawpoolsri, S, Charunwattana, P, Panapipat, S, White, N, Daya, N
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: 2014